Ironwood Pharmaceuticals Inc (NAS:IRWD)
$ 4.485 0.295 (7.04%) Market Cap: 716.43 Mil Enterprise Value: 1.21 Bil PE Ratio: 112.13 PB Ratio: 0 GF Score: 51/100

Ironwood Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 12, 2022 / 12:30PM GMT
Release Date Price: $11.42 (-1.38%)
Eric William Joseph
JPMorgan Chase & Co, Research Division - VP & Senior Analyst

Good morning, and thanks again for joining the 40th Annual JPMorgan Healthcare Conference. I'm Eric Joseph, senior biotech analyst with the firm. Our presenting -- first presenting company this morning is Ironwood Pharmaceuticals. And it's my pleasure to welcome CEO, Tom McCourt, to talk to us a little bit about the company. There is a Q&A session after the presentation. You can click the icon there to submit questions, and I'll work them in where appropriate. With that, Tom, thanks very much for joining us this morning.

Thomas A. McCourt
Ironwood Pharmaceuticals, Inc. - CEO & Director

Eric, thanks for having us. And I just want to thank JPMorgan for the opportunity to present to everybody today. For the last year, it's been an absolute privilege to be the new CEO of Ironwood Pharmaceuticals. And even in the midst of the global pandemic, our commitment to advancing the treatment of GI diseases and redefining standard of care for GI patients has been unwavering.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot